Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Celyad S.A.. (3/23/17). "Press Release: Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017". Mont-Saint-Guibert.

Organisations Organisation Celyad S.A. (Euronext Brussels + Paris: CYAD, Nasdaq: CYAD)
  Group Celyad (Group)
  Organisation 2 Ono Pharmaceutical Co., Ltd. (TSE: 4528)
  Group Ono Pharmaceutical (Group)
Products Product C-Cure® cell therapy
  Product 2 CAR-T technology (Chimeric Antigen Receptor T-Cell technology)
Persons Person Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007)
  Person 2 Jeanmart, Patrick (Celyad/Cardio3 BioSciences –201312–201812 CFO LEFT 12/18)
     


   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Celyad (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top